Literature DB >> 21233856

Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells.

Y Song1, M-M Dong, H-F Yang.   

Abstract

To explore the effects of RNA interference targeting four different genes (VEGF, C-myc, Survivin, hTERT) on the growth and proliferation of nasopharyngeal carcinoma (NPC) CNE-2Z cells. Fluorescein-labeled short-hairpin (sh)RNA plasmids together and separately targeting VEGF, C-myc, Survivin and hTERT were built and respectively called plasmid-shVEGF-shC-myc-shSurvivin-shhTERT, plasmid-shVEGF, plasmid-shC-myc, plasmid-shSurvivin, plasmid-shhTERT. These plasmids were respectively transfected into human NPC CNE-2Z cells and xenograft tumors in nude mice. The expression of plasmids in NPC CNE-2Z cells and xenograft tumors was observed. Cell proliferation was detected with MTT assay. The mRNA and protein expression were determined by real-time PCR and western blot, respectively. The effects of plasmids on the biological behavior of CNE-2Z cells were observed with transwell invision chamber models. Apoptosis was determined with flow cytometer. The inhibitory effect of plasmids on xenograft tumors was observed in nude mice. The plasmid containing four different shRNAs could significantly inhibit CNE-2Z cell proliferation and decrease invasion ability in vitro compared with plasmids with each single shRNA (P<0.05). The plasmid containing four different shRNAs could simultaneously downregulate VEGF, C-myc, surviving, hTERT mRNA and protein expression in the CNE-2Z cells. The multiple gene shRNA could more significantly induce cell apoptosis than each single shRNA, respectively (P<0.05). The combinative silencing of these four genes had a better inhibitory effect on xenograft tumors than the silencing of each single shRNA (P<0.05). RNA interference targeting multiple genes can effectively inhibit NPC proliferation and induce apoptosis, which provides an experiment basis for NPC gene therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233856     DOI: 10.1038/cgt.2010.80

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  6 in total

1.  T model of growth and its application in systems of tumor-immune dynamics.

Authors:  Mohammad A Tabatabai; Wayne M Eby; Karan P Singh; Sejong Bae
Journal:  Math Biosci Eng       Date:  2013-06       Impact factor: 2.080

2.  Early growth response protein-1 promoter-mediated synergistic antitumor effect of hTERTC27 gene therapy and 5-Flurorouracil on nasopharyngeal carcinoma.

Authors:  Guimiao Lin; Marie Chia-Mi Lin; Suxia Lin; Hong Yao; Shuihong Yu; Wanxian Yi; Gaixia Xu; Samuel Sai-Ming Ng; Siping Chen; Jing Yu; Xiaomei Wang; Baoxue Yang
Journal:  Cancer Biother Radiopharm       Date:  2012-09       Impact factor: 3.099

3.  Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line.

Authors:  Yan Liang; Xiangyong Li; Rongwen Lin; Xin Zhang; Huimin Wang; Ning Tan; Keshen Li; Xudong Tang; Keyuan Zhou; Tao Li
Journal:  Biomed Rep       Date:  2012-11-09

4.  Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.

Authors:  Rui Li; Hong-Qiang Yang; Hai-Lin Xi; Su Feng; Rui-Hao Qin
Journal:  Int J Oncol       Date:  2016-11-28       Impact factor: 5.650

5.  Optimization of Formulations Consisting of Layered Double Hydroxide Nanoparticles and Small Interfering RNA for Efficient Knockdown of the Target Gene.

Authors:  Yanheng Wu; Wenyi Gu; Chen Chen; Son Trong Do; Zhi Ping Xu
Journal:  ACS Omega       Date:  2018-05-02

6.  Knockdown of PNO1 inhibits esophageal cancer progression.

Authors:  Guowen Wang; Qicai Li; Chuankui Li; Guixin Duan; Haiwei Sang; Haijun Dong; Yifan Yang; Chang Ma; Tao Tao
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.